These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10193753)
1. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells. Masunaga S; Ono K; Hori H; Kinashi Y; Suzuki M; Takagaki M; Kasai S; Nagasawa H; Uto Y Int J Hyperthermia; 1999; 15(1):7-16. PubMed ID: 10193753 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia. Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144 [TBL] [Abstract][Full Text] [Related]
3. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967 [TBL] [Abstract][Full Text] [Related]
4. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia. Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M Jpn J Cancer Res; 1997 Aug; 88(8):770-7. PubMed ID: 9330609 [TBL] [Abstract][Full Text] [Related]
5. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status. Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells. Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503 [TBL] [Abstract][Full Text] [Related]
8. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia. Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells. Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769 [TBL] [Abstract][Full Text] [Related]
10. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Masunaga S; Ono K; Akaboshi M; Nishimura Y; Suzuki M; Kinashi Y; Takagaki M; Hiraoka M; Abe M Br J Cancer; 1997; 76(5):588-93. PubMed ID: 9303356 [TBL] [Abstract][Full Text] [Related]
11. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment. Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652 [TBL] [Abstract][Full Text] [Related]
12. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments. Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897 [TBL] [Abstract][Full Text] [Related]
13. Applicability of combination with tirapazamine in boron neutron capture therapy. Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984 [TBL] [Abstract][Full Text] [Related]
14. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons. Masunaga S; Sakurai Y; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Nagasawa H; Uto Y; Hori H; Ono K Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808 [TBL] [Abstract][Full Text] [Related]
15. Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M Int J Hyperthermia; 1997; 13(4):401-11. PubMed ID: 9278769 [TBL] [Abstract][Full Text] [Related]
16. An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen. Masunaga S; Ono K; Akaboshi M; Kawai K; Akuta K; Takagaki M; Suzuki M; Kinashi Y; Abe M J Cancer Res Clin Oncol; 1996; 122(9):533-40. PubMed ID: 8781567 [TBL] [Abstract][Full Text] [Related]
17. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays. Masunaga S; Nagasawa H; Uto Y; Hori H; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ono K Int J Hyperthermia; 2007 Feb; 23(1):29-35. PubMed ID: 17575721 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234 [TBL] [Abstract][Full Text] [Related]
19. Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration. Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H Jpn J Cancer Res; 2000 Jul; 91(7):731-6. PubMed ID: 10920281 [TBL] [Abstract][Full Text] [Related]
20. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy. Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]